Microbix Announces Leadership Transition

Microbix Biosystems (TSX:MBX) announced the appointment of Cameron Groome as its new president and CEO as the former, Vaughn Embro-Pantalony retired from that position.
As quoted in the press release:

Cameron Groome has been in the life sciences industry for more than 25 years, as a CEO, director, advisor, senior executive, investment banker and equity research analyst. He has been successful in operating, advising, financing and analyzing life sciences companies and has been a member of the board of directors and the audit committee of Microbix for the past five years. Mr. Groome is also a director of ScarX Therapeutics Corp. (Toronto), Naegis Pharmaceuticals Ltd. (Vancouver) and a member of the Global Affairs Canada life sciences advisory group (Ottawa).
William J. Gastle, founder and Executive Chairman of Microbix welcomed Mr. Groome to the CEO position at Microbix, stating, “We are pleased to have Cameron join us in this capacity. His abilities and knowledge of life sciences and Microbix should help drive us to greater success.”

Click here to read the full press release.

Source: www.marketwired.com